Double-Blind, Randomized, Placebo-Controlled Phase III Clinical Trial to Evaluate the Efficacy and Safety of treating Healthcare Professionals with the Adsorbed COVID-19 (Inactivated) Vaccine Manufactured by Sinovac - PROFISCOV . [Carta]: a structured summary of a study protocol for a randomised controlled trial (2020)
- Authors:
- Autor USP: KALLAS, ESPER GEORGES - FM
- Unidade: FM
- DOI: 10.1186/s13063-020-04775-4
- Subjects: COVID-19; PANDEMIAS; VACINAS; VACINAÇÃO; ENVELHECIMENTO; INCIDÊNCIA
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by
-
ABNT
PALACIOS, Ricardo et al. Double-Blind, Randomized, Placebo-Controlled Phase III Clinical Trial to Evaluate the Efficacy and Safety of treating Healthcare Professionals with the Adsorbed COVID-19 (Inactivated) Vaccine Manufactured by Sinovac - PROFISCOV . [Carta]: a structured summary of a study protocol for a randomised controlled trial. Trials. London: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://doi.org/10.1186/s13063-020-04775-4. Acesso em: 23 abr. 2024. , 2020 -
APA
Palacios, R., Patino, E. G., Piorelli, R. de O., Conde, M. T. R. P., Batista, A. P., Zeng, G., et al. (2020). Double-Blind, Randomized, Placebo-Controlled Phase III Clinical Trial to Evaluate the Efficacy and Safety of treating Healthcare Professionals with the Adsorbed COVID-19 (Inactivated) Vaccine Manufactured by Sinovac - PROFISCOV . [Carta]: a structured summary of a study protocol for a randomised controlled trial. Trials. London: Faculdade de Medicina, Universidade de São Paulo. doi:10.1186/s13063-020-04775-4 -
NLM
Palacios R, Patino EG, Piorelli R de O, Conde MTRP, Batista AP, Zeng G, Xin Q, Kallas EG, Flores J, Ockenhouse CF. Double-Blind, Randomized, Placebo-Controlled Phase III Clinical Trial to Evaluate the Efficacy and Safety of treating Healthcare Professionals with the Adsorbed COVID-19 (Inactivated) Vaccine Manufactured by Sinovac - PROFISCOV . [Carta]: a structured summary of a study protocol for a randomised controlled trial [Internet]. Trials. 2020 ; 21( 1):[citado 2024 abr. 23 ] Available from: https://doi.org/10.1186/s13063-020-04775-4 -
Vancouver
Palacios R, Patino EG, Piorelli R de O, Conde MTRP, Batista AP, Zeng G, Xin Q, Kallas EG, Flores J, Ockenhouse CF. Double-Blind, Randomized, Placebo-Controlled Phase III Clinical Trial to Evaluate the Efficacy and Safety of treating Healthcare Professionals with the Adsorbed COVID-19 (Inactivated) Vaccine Manufactured by Sinovac - PROFISCOV . [Carta]: a structured summary of a study protocol for a randomised controlled trial [Internet]. Trials. 2020 ; 21( 1):[citado 2024 abr. 23 ] Available from: https://doi.org/10.1186/s13063-020-04775-4 - Retention, engagement, and adherence to pre-exposure prophylaxis for men who have sex with men and transgender women in PrEP Brasil: 48 week results of a demonstration study
- Managing severe yellow fever in the intensive care [Editorial]: lessons learnt from Brazil
- A generalizable method for estimating duration of HIV infections using clinical testing history and HIV test results
- Vaccine-induced gag-specific T cells are associated with reduced viremia after HIV-1 infection
- Independent assessment of candidate HIV incidence assays on specimens in the CEPHIA repository
- Subsets of Memory CD4+ T Cell and Bactericidal Antibody Response to Neisseria meningitidis Serogroup C after Immunization of HIV-Infected Children and Adolescents
- Imbalanced expression of functional surface molecules in regulatory and effector T cells in systemic lupus erythematosus
- A side-by-side comparison of T cell reactivity to fifty-nine Mycobacterium tuberculosis antigens in diverse populations from five continents
- Persistent HIV Type 1 Seronegative Status Is Associated With Lower CD8+ T-Cell Activation
- Awareness and Willingness to Use Pre-exposure Prophylaxis (PrEP) Among Men Who Have Sex with Men and Transgender Women in Brazil
Informações sobre o DOI: 10.1186/s13063-020-04775-4 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas